Related Experiment Video

Updated: Aug 26, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
09:27

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells

Published on: April 2, 2021

Caspofungin in a pediatric patient with persistent candidemia

Karin K Wertz1, Robert K Pretzlaff

  • 1Department of Pediatrics, University of California, Davis Medical Center, Sacramento, CA, USA.

Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
|February 28, 2004
PubMed
Abstract

Insights

Caspofungin effectively treated a child with persistent candidemia, leading to recovery without toxicity. This echinocandin antifungal may be a valuable option for severe pediatric fungal infections unresponsive to standard treatments.

Area of Science:

  • Pediatric Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Persistent fungal infections in children pose significant treatment challenges.
  • Echinocandin antifungals offer a newer therapeutic option for invasive fungal diseases.
  • Current treatment guidelines for pediatric fungal infections are evolving.

Observation:

  • A 3-year-old female presented with persistent candidemia despite treatment with amphotericin B and flucytosine.
  • Caspofungin was added to the antifungal regimen after more than five weeks of persistent candidemia.
  • The patient was managed in a pediatric intensive care unit at a university teaching hospital.

Findings:

  • The addition of caspofungin led to rapid clearance of candidemia.
  • The child recovered clinically with no evidence of recurrent fungal infection.
  • No overt toxicity was observed during caspofungin treatment.

Implications:

  • Caspofungin demonstrated safety and potential efficacy in a pediatric patient with refractory candidemia.
  • This case suggests caspofungin could be considered for severe pediatric fungal infections unresponsive to conventional therapies.
  • Further research is warranted to establish the role of caspofungin in pediatric antifungal treatment protocols.

More Related Videos

Generation of Fluorescent Protein Fusions in Candida Species09:27

Generation of Fluorescent Protein Fusions in Candida Species

Published on: March 4, 2017

Related Concept Videos

Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...